{"archive_url":"https://www.ebi.ac.uk/ega/datasets/EGAD00001002379","experiment":{"EXPERIMENT_TYPE":"Histone H3K27ac","EXPERIMENT_ID":"EGAX00001326534","attributes":{"CHIP_ANTIBODY":["H3K27ac"],"CHIP_PROTOCOL_BEAD_TYPE":["magnetic beads A and G"],"EXTRACTION_PROTOCOL_SONICATION_CYCLES":["\"20 min; 30 sec ON/ 30 sec OFF\""],"CHIP_ANTIBODY_CATALOG":["BP grade"],"EXPERIMENT_TYPE":["Histone H3K27ac"],"CHIP_PROTOCOL_BEAD_AMOUNT":["20 ul"],"CHIP_ANTIBODY_LOT":["A1723-0041d"],"CHIP_PROTOCOL_ANTIBODY_AMOUNT":["1,0 ug"],"CHIP_PROTOCOL_CHROMATIN_AMOUNT":["1x 500.000 cells = 33 ul"],"EXTRACTION_PROTOCOL":["Chromatin was extracted using the histone protocol. Cells are crosslinked at 4 degrees 16 min in 1% formaldehyde. Washed twice in PBS and dissolved in shearing buffer (containing 1% SDS), such that the final concentration is 15*10^6 cells/ml."],"CHIP_PROTOCOL":["Protocol July 2014: 500.000 cells per ChIP. Overnight incubation of chromatin with antibody. 1 hour incubation in the morning with A/G magnetic beads. Wash once with buffer 1, and twice with buffer 2 and 3 at 4 degrees. Elute 20 min with elution buffer at RT. Descrosslink 4 hours at 65 degrees. Purify by column purification."],"CHIP_ANTIBODY_PROVIDER":["Diagenode"],"LIBRARY_GENERATION_FRAGMENT_SIZE_RANGE":["179"],"EXTRACTION_PROTOCOL_TYPE_OF_SONICATOR":["Bioruptor Plus (UCD-300)"]},"ASSAY_TYPE":"ChIP-Seq"},"archive":"EGA","ftp_path":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/bone_marrow/54168MM/Multiple_Myeloma/ChIP-Seq/NCMLS","files":[{"FORMAT":"bigBed","SIZE":"1.6M","NAME":"S00XFGH1.ERX1122529.H3K27ac.bwa.GRCh38.20151026.bb","FILE_TYPE":"CHIP_MACS2_BB","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/bone_marrow/54168MM/Multiple_Myeloma/ChIP-Seq/NCMLS/S00XFGH1.ERX1122529.H3K27ac.bwa.GRCh38.20151026.bb","PROTOCOL_DOC":"chip_seq_grch38","MD5":"0d81f0fac5dd0a39db77cc28e6a1f911"},{"FORMAT":"BED","SIZE":"1.9M","NAME":"S00XFGH1.ERX1122529.H3K27ac.bwa.GRCh38.20151026.bed.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/bone_marrow/54168MM/Multiple_Myeloma/ChIP-Seq/NCMLS/S00XFGH1.ERX1122529.H3K27ac.bwa.GRCh38.20151026.bed.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"4417135819d2cc6a93276f57ee5df8af"},{"FORMAT":"Text","SIZE":"2.2M","NAME":"S00XFGH1.ERX1122529.H3K27ac.bwa.GRCh38.20151026.xls.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/bone_marrow/54168MM/Multiple_Myeloma/ChIP-Seq/NCMLS/S00XFGH1.ERX1122529.H3K27ac.bwa.GRCh38.20151026.xls.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"5feb1fecab8ec35b60740a972f764f41"},{"FORMAT":"bigWig","SIZE":"967M","NAME":"S00XFGH1.ERX1122529.H3K27ac.bwa.GRCh38.20151029.bw","FILE_TYPE":"CHIP_WIGGLER","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Normalized signal","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/bone_marrow/54168MM/Multiple_Myeloma/ChIP-Seq/NCMLS/S00XFGH1.ERX1122529.H3K27ac.bwa.GRCh38.20151029.bw","PROTOCOL_DOC":"chip_seq_grch38","MD5":"2cd8081a1e5b8d5ece3334664d34afd8"}],"dataset_id":"EGAD00001002379","sample":{"SAMPLE_SOURCE":"bone marrow","SAMPLE_NAME":"54168MM","sample_barcode":"S00XFGH1","attributes":{"DISEASE":["Multiple Myeloma"],"CELL_TYPE":["plasma cell"],"DISEASE_ONTOLOGY_URI":[{"url":"4","label":"C0026764"}],"SAMPLE_ONTOLOGY_URI":[{"url":"6","label":"CL_0000786"}],"GENDER":["female"],"DONOR_ID":["54168MM"],"MARKERS":["CD138+"],"DONOR_HEALTH_STATUS":["Multiple Myeloma"],"MOLECULE":["genomic DNA"],"DONOR_AGE":["65 - 70"],"BIOMATERIAL_PROVIDER":["Jose I. Martin-Subero"],"TISSUE_TYPE":["bone marrow"],"BIOMATERIAL_TYPE":["Primary Cell"],"SUBJECT_ID":["54168MM"],"DONOR_SEX":["Female"],"DONOR_ETHNICITY":["NA"]},"SAMPLE_ID":"EGAN00001295806","SAMPLE_DESCRIPTION":"Multiple Myeloma"}}